相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cerebral neoplastic enhancing lesions: Multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0 M) and gadoterate meglumine (0.5 M) at 0.1 mmol Gd/kg body weight in a clinical setting
Nicoletta Anzalone et al.
EUROPEAN JOURNAL OF RADIOLOGY (2013)
Magnetic Resonance Evaluation of Brain Metastases From Systemic Malignances With Two Doses of Gadobutrol 1.0 M Compared With Gadoteridol A Multicenter, Phase II/III Study in Patients With Known or Suspected Brain Metastases
Nobuyuki Katakami et al.
INVESTIGATIVE RADIOLOGY (2011)
Dynamic Contrast Enhancement of Experimental Glioma: An Intra-individual Comparative Study to Assess the Optimal Time Delay
Tobias Engelhorn et al.
ACADEMIC RADIOLOGY (2010)
Contrast Material for Abdominal Dynamic Contrast-Enhanced 3D MR Angiography With Parallel Imaging: Intraindividual Equimolar Comparison of a Macrocyclic 1.0 M Gadolinium Chelate and a Linear Ionic 0.5 M Gadolinium Chelate
Dariusch Reza Hadizadeh et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Detection of Cerebral Metastases on Magnetic Resonance Imaging: Intraindividual Comparison of Gadobutrol with Gadopentetate Dimeglumine
Nicoletta Anzalone et al.
ACTA RADIOLOGICA (2009)
Comparative Evaluation of Lesion Enhancement Using 1 M Gadobutrol vs. 2 Conventional Gadolinium Chelates, All at a Dose of 0.1 mmol/kg, in a Rat Brain Tumor Model at 3 T
Ulrike I. Attenberger et al.
INVESTIGATIVE RADIOLOGY (2009)
Comparison of 1.0 M Gadobutrol and 0.5 M Gadopentetate Dimeglumine-Enhanced Magnetic Resonance Imaging in Five Hundred Seventy-Two Patients With Known or Suspected Liver Lesions Results of a Multicenter, Double-Blind, Interindividual, Randomized Clinical Phase-III Trial
Renate Hammerstingl et al.
INVESTIGATIVE RADIOLOGY (2009)
Extracellular gadolinium-based contrast media: An overview
Marie-France Bellin et al.
EUROPEAN JOURNAL OF RADIOLOGY (2008)
Extracellular gadolinium contrast agents: Differences in stability
S. K. Morcos
EUROPEAN JOURNAL OF RADIOLOGY (2008)
Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial
Bernd Tombach et al.
EUROPEAN RADIOLOGY (2008)
Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°C
Thomas Frenzel et al.
INVESTIGATIVE RADIOLOGY (2008)
Nephrogenic systemic fibrosis: More questions and some answers
S. K. Morcos et al.
NEPHRON CLINICAL PRACTICE (2008)
A multicenter, site-independent, blinded study to compare the diagnostic accuracy of contrast-enhanced magnetic resonance angiography using 1.0 M gadobutrol (Gadovist™) to intraarterial digital subtraction angiography in body arteries
Fritz K. W. Schaefer et al.
EUROPEAN JOURNAL OF RADIOLOGY (2007)
Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging:: a review
Jean-Marc Idee et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2006)
Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths
M Rohrer et al.
INVESTIGATIVE RADIOLOGY (2005)
Gadobutrol, a highly concentrated MR-imaging contrast agent,agent its physicochemical characteristics and the basis for its use in contrast-enhanced MR angiography and perfusion imaging
A Huppertz et al.
EUROPEAN RADIOLOGY (2004)
Value of 1.0-m gadolinium chelates: review of preclinical and clinical data on gadobutrol
B Tombach et al.
EUROPEAN RADIOLOGY (2002)
Using highly concentrated gadobutrol as an MR contrast agent in patients also requiring hemodialysis: Safety and dialysability
B Tombach et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2002)
0.5 M Gd chelate (Magnevist®) versus 1.0 M Gd chelate (Gadovist®):: Dose-independent effect on image quality of pelvic three-dimensional MR-angiography
M Goyen et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2001)
分享论文
